Skip to content

F.MED vs Virtual Incision

F.MED logo

F.MED

Development of microsurgery assist robot which support surgeon's small vessel anastomosis

1 employees · est. 2021 · Fukuoka, Japan

VS
Virtual Incision logo

Virtual Incision

Introducing the World’s First Miniaturized Robotic-Assisted Surgery (RAS) System. Follow us for updates!

33 employees · est. 2006 · Lincoln, United States

Virtual Incision is the older company (2021 vs 2006); Virtual Incision is the larger of the two.

Side-by-Side Comparison

F.MED Virtual Incision
Founded
2021 2006 older
Headquarters
Fukuoka, Japan Lincoln, United States
Employees
1 33 larger
Industry
Manufacturing, Medical Devices, Robotics Health Care, Manufacturing, Platforms
Funding Stage
Series A Series C
Total Funding
$430.00M $152.90M
Funding Rounds
1 13
Services
Not tracked yet Development of miniaturized robotic-assisted surgery systems, Deployment and integration of MIRA surgical system, Expansion of robotic surgery reach and accessibility
Target Customers
Not tracked yet Hospitals and healthcare facilities, Surgeons and medical practitioners, Patients requiring minimally invasive surgeries
Taxonomy
MicrosurgerySurgical RoboticsMinimally Invasive SurgerySurgical InnovationReconstructive SurgerySurgical Precision +2 Robotic-Assisted SurgeryMiniaturized Surgical RoboticsColon ResectionMIRA PlatformMinimally Invasive SurgerySurgical Innovation +5
Website
f-med.co.jp virtualincision.com
F.MED logo

About F.MED

F.MED is a Japan-based startup that is focused on the development of a microsurgery assist robot aimed at supporting small vessel anastomosis for surgeons. The company, founded in 2021, aims to address the challenges associated with microsurgery, which requires delicate and precise surgical tool man...

Virtual Incision logo

About Virtual Incision

Virtual Incision, founded in 2006 and based in Lincoln, Nebraska, is pioneering in the field of robotic-assisted surgery (RAS). With a compelling slogan: "Introducing the World’s First Miniaturized Robotic-Assisted Surgery (RAS) System," the company is tackling the challenge of making RAS more acces...

Also comparing in this category

Comparing more than these two?

Get F.MED, Virtual Incision and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does F.MED compare?

A PDF of F.MED and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

F.MED was founded in 2021, based in Fukuoka, Japan, with 1 employees. F.MED is a Japan-based startup that is focused on the development of a microsurgery assist robot aimed at supporting small vessel anastomosis for surgeons. The company, founded in 2021, aims to addres. Virtual Incision was founded in 2006, based in Lincoln, United States, with 33 employees. Virtual Incision, founded in 2006 and based in Lincoln, Nebraska, is pioneering in the field of robotic-assisted surgery (RAS). With a compelling slogan: "Introducing the World’s First Miniaturized Ro.
F.MED has raised $430.00M and Virtual Incision $152.90M. Latest stage: F.MED Series A, Virtual Incision Series C.
Both work in Manufacturing and Robotics and list minimally invasive surgery and surgical innovation among their focus areas.

Compare F.MED with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at F.MED on 13 Sep 2024, and Virtual Incision on 8 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout